Skip to main content
GENORAY Co., LTD. logo

GENORAY Co., LTD. — Investor Relations & Filings

Ticker · 122310 ISIN · KR7122310006 KO Manufacturing
Filings indexed 280 across all filing types
Latest filing 2022-05-17 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 122310

About GENORAY Co., LTD.

https://www.genoray.com/

GENORAY Co., LTD. is a developer and manufacturer of medical and dental X-ray imaging systems. Established in 2001, the company specializes in digital X-ray technology, providing diagnostic solutions for healthcare professionals globally. Its core product lines include mobile C-Arm systems for surgical applications, panoramic and cephalometric X-ray equipment, and Cone Beam CT (CBCT) scanners for advanced dental diagnostics. The company is also involved in the development of industrial X-ray systems. GENORAY focuses on technological innovation to enhance image quality and diagnostic capabilities, aiming to be a global leader in digital imaging.

Recent filings

Filing Released Lang Actions
[기재정정]분기보고서 (2022.03)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company '제노레이' (Genoray) for the first quarter of 2022. It contains detailed financial information, business descriptions, and management disclosures, which are characteristic of a comprehensive interim report. Although it is labeled as a '정정신고' (Correction Report), the content is the full quarterly report itself, not just an announcement of one. Therefore, it is classified as an Interim/Quarterly Report. Q1 2022
2022-05-17 Korean
분기보고서 (2022.03)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company 'Genoray' covering the period from January 1, 2022, to March 31, 2022. It contains detailed financial information, business operations, and management disclosures, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2022
2022-05-12 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the share ownership, changes in holdings (including market purchases), and collateral agreements of a major shareholder and their special related parties. This falls under the category of 'Major Shareholding Notification' (MRQ).
2022-05-11 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a 'Provisional Earnings Release' (영업(잠정)실적) for Genoray, detailing quarterly financial performance (revenue, operating profit, net income) for Q1 2022. It provides key financial highlights and comparisons to previous periods, which is the standard format for an Earnings Release (ER). It is not a full report, but rather the initial announcement of financial results. Q1 2022
2022-05-10 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding the scheduling and logistics of an Investor Relations (IR) meeting (기업설명회). It provides the date, time, location, and purpose of the meeting, and mentions that materials will be distributed at the event or available on the company website. Since this is an announcement of an event rather than the presentation slides themselves or a full financial report, it falls under the category of a regulatory filing announcement regarding corporate activities.
2022-05-09 Korean
[기재정정]현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 100% confidence The document is a regulatory filing from Genoray regarding a 'Cash/In-kind Dividend Decision'. It specifically details the dividend amount per share, the total dividend amount, the record date, and the payment date. This falls directly under the category of dividend announcements.
2022-04-11 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.